• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
oxycontin

Family Behind Purdue Pharma and OxyContin Faces Multiple Lawsuits

By
Renae Reints
Renae Reints
Down Arrow Button Icon
By
Renae Reints
Renae Reints
Down Arrow Button Icon
November 19, 2018, 4:07 PM ET

The Sackler family—members of which own Purdue Pharma, maker of the legal but highly addictive prescription painkiller OxyContin—is facing several lawsuits and a possible criminal investigation for its role in the opioid crisis, The Guardian reports.

Last month, New York’s Suffolk County filed a lawsuit that names eight Sackler family members across three generations who serve or have served on Purdue’s board. The lawsuit said the Sacklers “actively participated in conspiracy and fraud to portray the prescription painkiller as non-addictive, even though they knew it was dangerously addictive.”

The family has a net worth of $13 billion, according to Forbes.

“This is essentially a crime family … drug dealers in nice suits and dresses,” Paul Hanly, a New York City lawyer representing Suffolk County, told The Guardian. “What Purdue Pharma and the Sackler family have done to society through their aggressive peddling of opioids is unconscionable.”

In a statement to Fortune, Purdue Pharma said The Guardian‘s article “presents an inaccurate view of this complex legal matter,” adding that the “disinformation and ad hominem personal attacks” being put forth by the plaintiffs’ counsel only undermines real efforts to combat the opioid crisis, a “serious and complex public health problem.”

“The article relies heavily on comments from two contingency fee lawyers who are suing the Company for their own gain and who are willing to recklessly smear the reputations of companies and individuals in order to extract money in litigation,” the Purdue Pharma statement said of The Guardian‘s article. “Plaintiffs’ effort to name individual members of the Sackler family as defendants in the ongoing civil litigation is misguided and contradicts well established principles of law. These suits will be vigorously contested.”

Purdue Pharma and other opioid manufacturers are entangled in lawsuits across the country, with Purdue alone facing litigation from 30 states, according to The Guardian. In a 2007 case, Purdue executives unrelated to the Sacklers pleaded guilty to misleading doctors about OxyContin’s potential for abuse, resulting in Purdue paying out $600 million in fines.

Since then, the opioid crisis has only grown, with a record of nearly 72,000 people dying of drug overdose in 2017 alone.

Now, the family itself is facing a series of court battles. Along with the Suffolk County case, the Sacklers were sued by Massachusetts in June.

“For them it’s greed, it was all about profits over people,” Massachusetts attorney general Maura Healey told The Guardian. “I feel very confident naming the family members.”

The family members are also expected to be named in federal multi-district litigation in Ohio, and a source told The Guardian the family is also named in ongoing criminal investigations at the federal level. The Sacklers could not immediately be reached for comment.

Update: A statement from Purdue Pharma was added to this article after its initial publication.

About the Author
By Renae Reints
See full bioRight Arrow Button Icon

Latest in

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in

Alphabet and Google CEO Sundar Pichai seated next to Apple CEO Tim Cook at a formal dinner.
AIApple
What Apple’s AI deal with Google means for the two tech giants, and for $500 billion ‘upstart’ OpenAI
By Jeremy Kahn and Beatrice NolanJanuary 13, 2026
2 hours ago
Hubbard
Future of WorkJobs
Carhartt CEO says they always focused on blue-collar workers—but hipsters came anyway: ‘We welcome anyone … that wants to celebrate hard work’
By Nick LichtenbergJanuary 13, 2026
3 hours ago
Personal FinanceCertificates of Deposit (CDs)
Best certificates of deposit (CDs) for January 2026
By Glen Luke FlanaganJanuary 13, 2026
5 hours ago
A worker in a green jacket operates a welding tool.
EconomyLabor
U.S workers just took home their smallest share of capital since 1947, at least
By Sasha RogelbergJanuary 13, 2026
6 hours ago
A smartphone displaying the Google Gemini logo.
AIEye on AI
As ‘agentic commerce’ gains ground, companies shouldn’t put too much faith in ‘GEO,’ one industry insider warns
By Jeremy KahnJanuary 13, 2026
8 hours ago
BankingDebt
Why the $38 trillion national debt doomed Fed independence regardless of the Trump/Powell drama, top economist says
By Eva RoytburgJanuary 13, 2026
8 hours ago

Most Popular

placeholder alt text
Economy
Treasury spent $276 billion in interest on the national debt in the final three months of 2025, says the CBO—up $30 billion from a year prior
By Eleanor PringleJanuary 12, 2026
2 days ago
placeholder alt text
Newsletters
The oil CEO who stood up to Trump is a follower of the disciplined 'Exxon way' and has a history of blunt statements
By Jordan BlumJanuary 13, 2026
17 hours ago
placeholder alt text
Tech
Elon Musk asked people to upload their medical data to X so his AI company could learn to interpret MRIs and CT scans
By Sasha RogelbergJanuary 11, 2026
2 days ago
placeholder alt text
Economy
The longer the Supreme Court delays its tariff decision, the better it is for President Trump
By Jim EdwardsJanuary 13, 2026
16 hours ago
placeholder alt text
Success
An exec at $62 billion giant Colgate says Gen Z workers, despite getting flak for being woke and lazy, are actually ‘pushing us to get better’
By Emma BurleighJanuary 10, 2026
4 days ago
placeholder alt text
AI
'Godfather of AI' says the technology will create massive unemployment and send profits soaring — 'that is the capitalist system'
By Jason MaJanuary 12, 2026
1 day ago

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.